David M. Knott

Holdings History for LIGAND PHARMACEUTICALS INC - Common Stock (LGND)

Symbol: LGND on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2021	4.2%	0%	$10,449,000	75,000	0		$139.32	Q3 2021
30 Jun 2021	3.7%	0%	$9,839,000	75,000	0		$131.19	Q2 2021
31 Mar 2021	4.9%	-11%	$11,434,000	75,000	-173,041	-70%	$152.45	Q1 2021
31 Dec 2020	11%	0%	$24,667,000	248,041	0		$99.45	Q4 2020
30 Sep 2020	14%	-1.4%	$23,644,000	248,041	-25,000	-9.2%	$95.32	Q3 2020
30 Jun 2020	17%	-4.9%	$30,540,000	273,041	-80,000	-23%	$111.85	Q2 2020
31 Mar 2020	16%	0%	$25,673,000	353,041	0		$72.72	Q1 2020
31 Dec 2019	15%	0%	$36,819,000	353,041	0		$104.29	Q4 2019
30 Sep 2019	15%	0%	$35,141,000	353,041	0		$99.54	Q3 2019
30 Jun 2019	17%	+0.43%	$40,299,000	353,041	+9,000	+2.6%	$114.15	Q2 2019
31 Mar 2019	17%	0%	$43,250,000	344,041	0		$125.71	Q1 2019
31 Dec 2018	22%	0%	$46,686,000	344,041	0		$135.70	Q4 2018
30 Sep 2018	31%	0%	$94,436,000	344,041	0		$274.49	Q3 2018
30 Jun 2018	27%	-16%	$71,275,000	344,041	-209,000	-38%	$207.17	Q2 2018
31 Mar 2018	38%	-14%	$91,340,000	553,041	-209,903	-28%	$165.16	Q1 2018
31 Dec 2017	42%	-1.9%	$104,470,000	762,944	-35,156	-4.4%	$136.93	Q4 2017
30 Sep 2017	46%	-12%	$108,661,000	798,100	-200,000	-20%	$136.15	Q3 2017
30 Jun 2017	51%	0%	$121,170,000	998,100	0		$121.40	Q2 2017
31 Mar 2017	51%	0%	$105,639,000	998,100	0		$105.84	Q1 2017
31 Dec 2016	51%	0%	$101,417,000	998,100	0		$101.61	Q4 2016
30 Sep 2016	53%	-11%	$101,866,000	998,100	-201,666	-17%	$102.06	Q3 2016
30 Jun 2016	33%	0%	$143,096,091	1,199,766	0		$119.27	Q2 2016
31 Mar 2016	34%	0%	$128,482,941	1,199,766	0		$107.09	Q1 2016
31 Dec 2015	36%	0%	$130,078,630	1,199,766	0		$108.42	Q4 2015
30 Sep 2015	30%	-1.2%	$102,759,958	1,199,766	-50,000	-4%	$85.65	Q3 2015
30 Jun 2015	26%	0%	$126,101,389	1,249,766	0		$100.90	Q2 2015
31 Mar 2015	21%	0%	$96,369,456	1,249,766	0		$77.11	Q1 2015
31 Dec 2014	16%	0%	$66,500,049	1,249,766	0		$53.21	Q4 2014
30 Sep 2014	11%	0%	$58,726,504	1,249,766	0		$46.99	Q3 2014
30 Jun 2014	14%	0%	$77,847,923	1,249,766	0		$62.29	Q2 2014
31 Mar 2014	16%	-0.55%	$84,071,759	1,249,766	-42,800	-3.3%	$67.27	Q1 2014
31 Dec 2013	14%	0%	$67,988,972	1,292,566	0		$52.60	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.